Medicare approves WashU Medicine’s whole-genome test for blood cancers @washumedicine
Medicare approves WashU Medicine’s whole-genome test for blood cancers  @washumedicine
Uploaded August 2023 | Updated November 2026, 5 days ago
ChromoSeq is the name of a new test for two blood cancers – a test developed by a team at Washington University School of Medicine in St. Louis. ChromoSeq is the first whole-genome sequencing test for cancer to be approved for reimbursement by the Centers for Medicare & Medicaid Services. For more information, see here: https://medicine.wustl.edu/news/medicare-approves-washu-medicines-whole-genome-test-for-blood-cancers/

Video by Katie Gertler/Washington University School of Medicine in St. Louis
Medicare approves WashU Medicine’s whole-genome test for blood cancersResidency and fellowship training at the School of MedicineAnthony Fauci: Insights into the COVID-19 pandemicAnthony Fauci, MD, delivers WashU Medicine Commencement speech 2023The Cure Within: a first in the treatment of sickle cell diseaseI knew WashU was for me - William on the Master of Science in Deaf Education (MSDE)Revving up immune system may help treat eczemaHighlights from CDC director Walensky’s conversation about COVID-19 pandemicWhite Coat ceremony at Washington University School of MedicineMatch Day 2026 | WashU MedicineIn Our Lifetime — Part 1: A Piece of MeWhat inspires Kerri Morgan, PhD, OTR/L, ATP and her work at WashU Medicine
WashU Medicine |

Medicare approves WashU Medicine’s whole-genome test for blood cancers

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER